Refinement and Reproducibility of Histologic Criteria for the Assessment of Microscopic Lesions in Patients with Gastroesophageal Reflux Disease: the Esohisto Project
Standardized criteria for assessing microscopic esophageal lesions are required to test their utility as markers of gastroesophageal reflux disease (GERD).
To finalize draft criteria for assessing microscopic esophageal lesions associated with gastroesophageal reflux and to test them for interobserver agreement.
An international group of gastrointestinal pathologists was convened to finalize, using a consensus-based approach, draft criteria for recognizing microscopic esophageal lesions. Finalized criteria were retested for interobserver variability by four of the pathologists using 120 digitized esophageal biopsy slides from patients with GERD.
The finalized criteria included further clarification on lesion definitions and new guidance on how to select the area for assessing each lesion. This latter refinement was guided by the high interobserver agreement observed when draft criteria were previously applied to biopsies where the assessment area was preselected. When finalized criteria were applied in the current study to digitized biopsies without a preselected assessment area, the pairwise agreement was 73–97% for basal cell hyperplasia, papillary elongation, intraepithelial eosinophil, neutrophil and mononuclear cell numbers, and active/healed erosions, with slightly lower agreement (64%) for dilated intercellular spaces (DIS). When a combined severity score was applied, the level of agreement was 77%. The mean kappa ranged from fair to high (0.26–0.77) for individual lesions and was high for the combined score (0.64).
These levels of agreement are comparable with or higher than those for other accepted histologic definitions. Further steps include clinical validation of these criteria by correlating microscopic lesions with clinical variables such as esophageal acid exposure.
KeywordsGastroesophageal reflux Esophagitis Histology Observer variation Consensus
We thank Aperio Technologies Inc., Vista, California, USA, for scanning the biopsy specimen slides and for providing the digital pathology management software. We gratefully acknowledge Dr. Kaiyo Takubo for his role in helping to develop and test the histologic criteria in this study. AstraZeneca R&D, Mölndal, Sweden, provided economic support for the travel, logistics, and statistical analysis. Writing assistance funded by AstraZeneca R&D, Mölndal, Sweden, was provided by Dr. Anja Becher and Dr. Michael Molloy-Bland from Oxford PharmaGenesis.
- 6.Zagari RM, Pozzato P, Nicolini G, et al. Prevalence of asymptomatic endoscopic lesions of the upper gastrointestinal tract. Preliminary results of The Loiano-Monghidoro population study. Gastroenterology. 2002;122:A208.Google Scholar
- 19.Cooper HS, Dayal Y, Gourley WK, et al. Proceedings of the 1988 Subspecialty Conference on Gastrointestinal Pathology at the USCAP. United States and Canadian Academy of Pathology. Diagnostic nonproblems in gastrointestinal biopsy pathology. Mol Pathol. 1989;2:244–259.Google Scholar
- 20.Mitros FA. Atlas of gastrointestinal pathology. Philadelphia: Lippincott; 1988:1.2–1.12.Google Scholar
- 21.Sternberg SS. Histology for pathologists. 2nd ed. Philadelphia: Lippincott; 1997:468.Google Scholar